Maraviroc
Maraviroc: 2 brands, 4 generics; first approved Aug 06, 2007; generic available.
Generic available: 4 ANDA applications approved.
Brand (NDA) products
- VIIV HLTHCARENDA 2089842016
Approved strengths under this FDA application. Strength Dosage form Route Status TE 20MG/ML SOLUTION ORAL Rx — - SELZENTRYRLDVIIV HLTHCARENDA 02212820164 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 150MG TABLET ORAL Rx AB 300MG TABLET ORAL Rx AB 25MG TABLET ORAL Discontinued — 75MG TABLET ORAL Discontinued —
Generic (ANDA) products (4)
- MARAVIROCRHODES PHARMSANDA 21614320252 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 150MG TABLET ORAL Discontinued — 300MG TABLET ORAL Discontinued — - MARAVIROCNAVINTA LLCANDA 21788020252 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 150MG TABLET ORAL Rx AB 300MG TABLET ORAL Rx AB - MARAVIROCI 3 PHARMSANDA 21711420232 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 150MG TABLET ORAL Rx AB 300MG TABLET ORAL Rx AB - MARAVIROCHETERO LABS LTD IIIANDA 20334720222 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 150MG TABLET ORAL Rx AB 300MG TABLET ORAL Rx AB
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Approval history
Approvals span 2007–2025 across 6 FDA applications.
Maraviroc: frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
Go beyond the database.
Try Assyro Intelligence for your regulatory research. Ready to discuss your team’s workflow? Book a demo.